.jpg)
Chugai allots S$200 million for
Singapore R&D research MANUFACTURING
| Staff Reporter, Singapore
Published: 16 Jul 12 New investment will be spent over five years
to develop innovative drugs "to serve unmet medical needs".Minister
Lim Hng Kiang confirmed the fresh funds in a speech marking the opening of
Chugai's Singapore R&D research centre, Singapore’s first corporate
laboratory in the area of antibody engineering, ."Following Chugai’s first
research centre in Singapore ,
Chugai Pharmabody Research will build on Chugai’s existing R&D success by
focusing on antibody research. In this regard, I am heartened to note that
Chugai will be investing close to S$200 million over the next five years to
developing and making innovative drugs at the facility to serve unmet medical
needs," the minister said."We therefore welcome Chugai Pharmabody
Research to form new partnerships within the clinical and research community
here and leverage our diverse R&D talent, capabilities and expertise to
translate research into quality healthcare solutions," he added.The
minister said that the government for its part, is keen on investing in
biomedical sciences research to attract more companies like Chugai to undertake
cutting-edge work in Singapore."Between year 2011 and 2015, we will invest
$3.7 billion in biomedical sciences research. This is a 12 per cent increase
from the preceding five years. Our investments will help pave the way for the
biomedical research community in Singapore to engage meaningfully in
industry-relevant research collaborations. In addition, it will enable them to
stay at the forefront of science," he said.
No comments:
Post a Comment